Advances in Complement-Targeted Therapy for IgA Nephropathy

Complement-targeted therapy represents a promising novel approach for IgAN treatment, and overcoming current barriers is essential to facilitate the advancement of individualized precision therapy for the condition.

Institutions

Publication Details

Journal
Kidney Diseases
Published
2025-12-18
DOI
https://doi.org/10.1159/000550108
Primary Topic
Renal Diseases and Glomerulopathies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Advances in Complement-Targeted Therapy for IgA Nephropathy

Kidney Diseases
Renal Diseases and Glomerulopathies
article

Advances in Complement-Targeted Therapy for IgA Nephropathy

article en

Abstract

Complement-targeted therapy represents a promising novel approach for IgAN treatment, and overcoming current barriers is essential to facilitate the advancement of individualized precision therapy for the condition.

Kidney DiseasesVol. 12(1)
University of Electronic Science and Technology of China (CN)
Good health and well-being
Openalex Percentile: Top 33%
Renal Diseases and Glomerulopathies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Advances in Complement-Targeted Therapy for IgA Nephropathy · Kidney Diseases (2025) | TGRS Research Map | TGRS